![Frontiers | Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels Frontiers | Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels](https://www.frontiersin.org/files/Articles/326326/fbioe-06-00007-HTML-r1/image_m/fbioe-06-00007-g001.jpg)
Frontiers | Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels
![Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies - Masabumi Shibuya, 2011 Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies - Masabumi Shibuya, 2011](https://journals.sagepub.com/cms/10.1177/1947601911423031/asset/images/large/10.1177_1947601911423031-fig1.jpeg)
Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies - Masabumi Shibuya, 2011
![Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia - ScienceDirect Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0969996114002435-fx1.jpg)
Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia - ScienceDirect
![A Vascular Endothelial Growth Factor-Dependent Sprouting Angiogenesis Assay Based on an In Vitro Human Blood Vessel Model for the Study of Anti-Angiogenic Drugs - eBioMedicine A Vascular Endothelial Growth Factor-Dependent Sprouting Angiogenesis Assay Based on an In Vitro Human Blood Vessel Model for the Study of Anti-Angiogenic Drugs - eBioMedicine](https://www.thelancet.com/cms/asset/fd5b1f32-47d0-4c38-8709-56fcd3b77cbf/gr1.jpg)
A Vascular Endothelial Growth Factor-Dependent Sprouting Angiogenesis Assay Based on an In Vitro Human Blood Vessel Model for the Study of Anti-Angiogenic Drugs - eBioMedicine
![The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: multiple copy flexibility and receptor binding: Structure The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: multiple copy flexibility and receptor binding: Structure](https://www.cell.com/cms/attachment/521931/3555668/gr1.jpg)
The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: multiple copy flexibility and receptor binding: Structure
![Vascular endothelial growth factor: a neurovascular target in neurological diseases | Nature Reviews Neurology Vascular endothelial growth factor: a neurovascular target in neurological diseases | Nature Reviews Neurology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrneurol.2016.88/MediaObjects/41582_2016_Article_BFnrneurol201688_Fig1_HTML.jpg)
Vascular endothelial growth factor: a neurovascular target in neurological diseases | Nature Reviews Neurology
![Novel Target for Limiting VEGF-A (Vascular Endothelial Growth Factor A)–Induced Vascular Permeability | Arteriosclerosis, Thrombosis, and Vascular Biology Novel Target for Limiting VEGF-A (Vascular Endothelial Growth Factor A)–Induced Vascular Permeability | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/98ad0e95-6c28-49b3-9dc5-e0a5dcaa966d/atvbaha.122.318105.fig01.jpg)
Novel Target for Limiting VEGF-A (Vascular Endothelial Growth Factor A)–Induced Vascular Permeability | Arteriosclerosis, Thrombosis, and Vascular Biology
![Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial: Molecular Therapy - Methods & Clinical Development Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/8ef691ba-7f22-4c0d-b46c-54325b81c0fa/fx1_lrg.jpg)
Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial: Molecular Therapy - Methods & Clinical Development
![IJMS | Free Full-Text | Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response IJMS | Free Full-Text | Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response](https://pub.mdpi-res.com/ijms/ijms-22-04871/article_deploy/html/images/ijms-22-04871-g001.png?1620288138)
IJMS | Free Full-Text | Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response
![Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-VEGFR2 antibody on gastric cancer in vivo | Scientific Reports Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-VEGFR2 antibody on gastric cancer in vivo | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-94584-9/MediaObjects/41598_2021_94584_Fig6_HTML.png)